Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cross Country Healthcare (CCRN) Current Leases (2019 - 2025)

Cross Country Healthcare's Current Leases history spans 7 years, with the latest figure at $1.2 million for Q4 2025.

  • For Q4 2025, Current Leases fell 44.33% year-over-year to $1.2 million; the TTM value through Dec 2025 reached $1.2 million, down 44.33%, while the annual FY2025 figure was $1.2 million, 44.33% down from the prior year.
  • Current Leases reached $1.2 million in Q4 2025 per CCRN's latest filing, up from $846000.0 in the prior quarter.
  • In the past five years, Current Leases ranged from a high of $4.8 million in Q1 2021 to a low of $846000.0 in Q3 2025.
  • Average Current Leases over 5 years is $3.0 million, with a median of $3.0 million recorded in 2023.
  • Peak YoY movement for Current Leases: increased 2.91% in 2022, then tumbled 58.93% in 2025.
  • A 5-year view of Current Leases shows it stood at $4.1 million in 2021, then grew by 1.03% to $4.1 million in 2022, then plummeted by 36.98% to $2.6 million in 2023, then dropped by 19.78% to $2.1 million in 2024, then plummeted by 44.33% to $1.2 million in 2025.
  • Per Business Quant, the three most recent readings for CCRN's Current Leases are $1.2 million (Q4 2025), $846000.0 (Q3 2025), and $1.3 million (Q2 2025).